It is a pharma private limited company based in Sangareddy, Telangana, India, established in 2017.
2017 | Sangareddy, Telangana, India | ActiveSynfine Drugs Private Limited, a active private limited company, was established on 20 March 2017 in Sangareddy, Telangana, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24304TG2017PTC116006. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹11.00 Cr and a paid-up capital of ₹4.87 Cr.
It upholds a compliant status. Employing 21 professional, Its leadership includes Saida Reddy Battu (Managing Director), Chandra Kala Battu (Director). It holds ₹11.00 Cr open charges and ₹9.51 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Survey No, 637, Temple Road, Bonthapally (Village) Gummadidala (Mandal), Sangareddy, Telangana, 502313.
U24304TG2017PTC116006
116006
20 March 2017
₹11.00 Cr
₹4.87 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Synfine Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saida Reddy Battu | Managing Director | 20 Mar 2017 | Current |
| Chandra Kala Battu | Director | 20 Mar 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synfine Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.49% increase. The company also saw a substantial improvement in profitability, with a 2472.93% increase in profit. The company's net worth Soared by an impressive increase of 29.72%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Synfine Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹110,000,000.00
₹95,100,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2024 | Others | ₹9.00 Cr | Open |
| 21 Nov 2024 | Others | ₹2.00 Cr | Open |
| 04 Sep 2019 | State Bank Of India | ₹9.51 Cr | Satisfied |
Explore comprehensive loan charge details -
Synfine Drugs has a workforce of 21 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Synfine Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synfine Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 9.00 Cr with Charge ID 101022083 was registered on 21 Nov 2024. was documented.
Progress on A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101021956 was registered on 21 Nov 2024. was documented.
Progress on A charge registered on 04 Sep 2019 via Charge ID 100290357 with State Bank Of India was fully satisfied on 18 Nov 2024. was documented.
Progress on Synfine Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Synfine Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
A charge with State Bank Of India of Rs. 9.51 Cr registered on 04 Sep 2019 with Charge ID 100290357 was modified on 07 Jun 2023. was recorded as a recent event.
The CIN of Synfine Drugs Private Limited is U24304TG2017PTC116006.
Synfine Drugs Private Limited is headquartered at Survey No, 637, Temple Road, Bonthapally (Village) Gummadidala (Mandal), Sangareddy, Telangana, 502313.
Synfine Drugs Private Limited was incorporated on 20 March 2017.
The current directors of Synfine Drugs Private Limited are
The primary industry of Synfine Drugs Private Limited is Manufacturing.
Synfine Drugs Private Limited is unlisted.
The authorized capital of Synfine Drugs Private Limited is ₹11.00 Cr, and the paid-up capital is ₹4.87 Cr.
The compliance status of Synfine Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX